675 related articles for article (PubMed ID: 31801915)
1. Generation of novel Il2rg-knockout mice with clustered regularly interspaced short palindromic repeats (CRISPR) and Cas9.
Byambaa S; Uosaki H; Hara H; Nagao Y; Abe T; Shibata H; Nureki O; Ohmori T; Hanazono Y
Exp Anim; 2020 Apr; 69(2):189-198. PubMed ID: 31801915
[TBL] [Abstract][Full Text] [Related]
2. Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1.
Schiroli G; Ferrari S; Conway A; Jacob A; Capo V; Albano L; Plati T; Castiello MC; Sanvito F; Gennery AR; Bovolenta C; Palchaudhuri R; Scadden DT; Holmes MC; Villa A; Sitia G; Lombardo A; Genovese P; Naldini L
Sci Transl Med; 2017 Oct; 9(411):. PubMed ID: 29021165
[TBL] [Abstract][Full Text] [Related]
3. Generation of knockout rabbits with X-linked severe combined immunodeficiency (X-SCID) using CRISPR/Cas9.
Hashikawa Y; Hayashi R; Tajima M; Okubo T; Azuma S; Kuwamura M; Takai N; Osada Y; Kunihiro Y; Mashimo T; Nishida K
Sci Rep; 2020 Jun; 10(1):9957. PubMed ID: 32561775
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants.
Sweeney CL; Choi U; Liu C; Koontz S; Ha SK; Malech HL
Hum Gene Ther; 2017 Jul; 28(7):565-575. PubMed ID: 28264583
[TBL] [Abstract][Full Text] [Related]
5. Biological Characteristics of Severe Combined Immunodeficient Mice Produced by CRISPR/Cas9-Mediated
Zhao Y; Liu P; Xin Z; Shi C; Bai Y; Sun X; Zhao Y; Wang X; Liu L; Zhao X; Chen Z; Zhang H
Front Genet; 2019; 10():401. PubMed ID: 31134127
[TBL] [Abstract][Full Text] [Related]
6. Non-viral
Byambaa S; Uosaki H; Ohmori T; Hara H; Endo H; Nureki O; Hanazono Y
Mol Ther Methods Clin Dev; 2021 Mar; 20():451-462. PubMed ID: 33614821
[TBL] [Abstract][Full Text] [Related]
7. Off- and on-target effects of genome editing in mouse embryos.
Ayabe S; Nakashima K; Yoshiki A
J Reprod Dev; 2019 Feb; 65(1):1-5. PubMed ID: 30518723
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
Liu W; Yang C; Liu Y; Jiang G
Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
[TBL] [Abstract][Full Text] [Related]
9. Optimisation of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 : single-guide RNA (sgRNA) delivery system in a goat model.
Huang Y; Ding Y; Liu Y; Zhou S; Ding Q; Yan H; Ma B; Zhao X; Wang X; Chen Y
Reprod Fertil Dev; 2019 Aug; 31(9):1533-1537. PubMed ID: 31079595
[TBL] [Abstract][Full Text] [Related]
10. Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing.
Hou Y; Ureña-Bailén G; Mohammadian Gol T; Gratz PG; Gratz HP; Roig-Merino A; Antony JS; Lamsfus-Calle A; Daniel-Moreno A; Handgretinger R; Mezger M
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553615
[TBL] [Abstract][Full Text] [Related]
11. Efficient genome editing of Brassica campestris based on the CRISPR/Cas9 system.
Xiong X; Liu W; Jiang J; Xu L; Huang L; Cao J
Mol Genet Genomics; 2019 Oct; 294(5):1251-1261. PubMed ID: 31129735
[TBL] [Abstract][Full Text] [Related]
12. Biallelic modification of IL2RG leads to severe combined immunodeficiency in pigs.
Kang JT; Cho B; Ryu J; Ray C; Lee EJ; Yun YJ; Ahn S; Lee J; Ji DY; Jue N; Clark-Deener S; Lee K; Park KW
Reprod Biol Endocrinol; 2016 Nov; 14(1):74. PubMed ID: 27809915
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg
Wei X; Lai Y; Li B; Qin L; Xu Y; Lin S; Wang S; Wu Q; Liang Q; Huang G; Deng Q; Liu P; Wu D; Lai L; Yao Y; Li P
Sci Rep; 2017 Aug; 7(1):7720. PubMed ID: 28798321
[TBL] [Abstract][Full Text] [Related]
14. Bacterial and
Song J; Wang G; Hoenerhoff MJ; Ruan J; Yang D; Zhang J; Yang J; Lester PA; Sigler R; Bradley M; Eckley S; Cornelius K; Chen K; Kolls JK; Peng L; Ma L; Chen YE; Sun F; Xu J
Front Immunol; 2018; 9():429. PubMed ID: 29593714
[TBL] [Abstract][Full Text] [Related]
15. A single blastocyst assay optimized for detecting CRISPR/Cas9 system-induced indel mutations in mice.
Sakurai T; Watanabe S; Kamiyoshi A; Sato M; Shindo T
BMC Biotechnol; 2014 Jul; 14():69. PubMed ID: 25042988
[TBL] [Abstract][Full Text] [Related]
16. A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9.
Sui T; Lau YS; Liu D; Liu T; Xu L; Gao Y; Lai L; Li Z; Han R
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29871865
[TBL] [Abstract][Full Text] [Related]
17. Suppression of mosaic mutation by co-delivery of CRISPR associated protein 9 and three-prime repair exonuclease 2 into porcine zygotes via electroporation.
Yamashita S; Kogasaka Y; Hiradate Y; Tanemura K; Sendai Y
J Reprod Dev; 2020 Feb; 66(1):41-48. PubMed ID: 31761839
[TBL] [Abstract][Full Text] [Related]
18. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 with improved proof-reading enhances homology-directed repair.
Kato-Inui T; Takahashi G; Hsu S; Miyaoka Y
Nucleic Acids Res; 2018 May; 46(9):4677-4688. PubMed ID: 29672770
[TBL] [Abstract][Full Text] [Related]
19. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
20. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
